HealthEconomics.com publishes a fortnightly newsletter, with the latest edition available here. Their site and newsletter is very US focused, but some of these stories are relevant to Europe and non-US stories frequently make their way into it.
In Newsletter No. 59 there is news of Spain's pricing and reimbursement policy, a study comparing drug prices across various countries, analysis on the cost-effectiveness of rosuvastatin and a personal perspective on evidence-based medicine from David Eddy.
